|
1
|
Barbui T, Thiele J, Gisslinger H, Kvasnicka HM, Vannucchi AM, Guglielmelli P, Orazi A and Tefferi A: The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion. Blood Cancer J. 8:152018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tremblay D, Yacoub A and Hoffman R: Overview of myeloproliferative neoplasms: History, pathogenesis, diagnostic criteria, and complications. Hematol Oncol Clin North Am. 35:159–176. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rampal R, Al-Shahrour F, Abdel-Wahab O, Patel JP, Brunel JP, Mermel CH, Bass AJ, Pretz J, Ahn J, Hricik T, et al: Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis. Blood. 123:e123–e133. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
James C, Ugo V, Le Couédic JP, Staerk J, Delhommeau F, Lacout C, Garçon L, Raslova H, Berger R, Bennaceur-Griscelli A, et al: A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 434:1144–1148. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pardanani AD, Levine RL, Lasho T, Pikman Y, Mesa RA, Wadleigh M, Steensma DP, Elliott MA, Wolanskyj AP, Hogan WJ, et al: MPL515 mutations in myeloproliferative and other myeloid disorders: A study of 1182 patients. Blood. 108:3472–3476. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD, Them NC, Berg T, Gisslinger B, Pietra D, et al: Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med. 369:2379–2390. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Patel AA and Odenike O: Genomics of MPN progression. Hematology (Am Soc Hematol Educ Program). 2020:440–449. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brkic S and Meyer SC: Challenges and perspectives for therapeutic targeting of myeloproliferative neoplasms. HemaSphere. 5:e5162020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tefferi A: Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management. Am J Hematol. 96:145–162. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Siliņa K, Zayakin P, Kalniņa Z, Ivanova L, Meistere I, Endzeliņš E, Abols A, Stengrēvics A, Leja M, Ducena K, et al: Sperm-associated antigens as targets for cancer immunotherapy: Expression pattern and humoral immune response in cancer patients. J Immunother. 34:28–44. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu Y, Zhang L, Li W, Huang Q, Yuan S, Li Y, Liu J, Zhang S, Pin G, Song S, et al: The sperm-associated antigen 6 interactome and its role in spermatogenesis. Reproduction. 158:181–197. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu X, Yan R, Cheng X, Song L, Zhang W, Li K and Zhao S: The function of sperm-associated antigen 6 in neuronal proliferation and differentiation. J Mol Histol. 47:531–540. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Coan M, Rampioni Vinciguerra GL, Cesaratto L, Gardenal E, Bianchet R, Dassi E, Vecchione A, Baldassarre G, Spizzo R and Nicoloso MS: Exploring the role of fallopian ciliated cells in the pathogenesis of high-grade serous ovarian cancer. Int J Mol Sci. 19:25122018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Steinbach D, Bader P, Willasch A, Bartholomae S, Debatin KM, Zimmermann M, Creutzig U, Reinhardt D and Gruhn B: Prospective validation of a new method of monitoring minimal residual disease in childhood acute myelogenous leukemia. Clin Cancer Res. 21:1353–1359. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mulaw MA, Krause A, Deshpande AJ, Krause LF, Rouhi A, La Starza R, Borkhardt A, Buske C, Mecucci C, Ludwig WD, et al: CALM/AF10-positive leukemias show upregulation of genes involved in chromatin assembly and DNA repair processes and of genes adjacent to the breakpoint at 10p12. Leukemia. 26:1012–1019. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jiang M, Chen Y, Deng L, Luo X, Wang L and Liu L: Upregulation of SPAG6 in myelodysplastic syndrome: Knockdown inhibits cell proliferation via AKT/FOXO signaling pathway. DNA Cell Biol. 38:476–484. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang R, Zhu H, Yuan Y, Wang Y and Tian Z: SPAG6 promotes cell proliferation and inhibits apoptosis through the PTEN/PI3K/AKT pathway in Burkitt lymphoma. Oncol Rep. 44:2021–2030. 2020.PubMed/NCBI
|
|
18
|
Mijnes J, Tiedemann J, Eschenbruch J, Gasthaus J, Bringezu S, Bauerschlag D, Maass N, Arnold N, Weimer J, Anzeneder T, et al: SNiPER: A novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection. Oncotarget. 10:6494–6508. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Altenberger C, Heller G, Ziegler B, Tomasich E, Marhold M, Topakian T, Müllauer L, Heffeter P, Lang G, End-Pfützenreuter A, et al: SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers. Mol Cancer. 16:12017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zheng DF, Wang Q, Wang JP, Bao ZQ, Wu SW, Ma L, Chai DM, Wang ZP and Tao YS: The emerging role of sperm-associated antigen 6 gene in the microtubule function of cells and cancer. Mol Ther Oncolytics. 15:101–107. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li X, Xu L, Sun G, Wu X, Bai X, Li J, Strauss JF, Zhang Z and Wang H: Spag6 mutant mice have defects in development and function of spiral ganglion neurons, apoptosis, and higher sensitivity to paclitaxel. Sci Rep. 7:86382017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang M, Luo J, Luo X and Liu L: SPAG6 silencing induces autophagic cell death in SKM-1 cells via the AMPK/mTOR/ULK1 signaling pathway. Oncol Lett. 20:551–560. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang Y, Xiao M, Song Y, Tang Y, Luo T, Yang S, He W, Cheng Q, Ma L, Zhang Y, et al: H-score of 11β-hydroxylase and aldosterone synthase in the histopathological diagnosis of adrenocortical tumors. Endocrine. 65:683–691. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehár J, Kryukov GV, Sonkin D, et al: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 483:603–607. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kitchen MO, Bryan RT, Haworth KE, Emes RD, Luscombe C, Gommersall L, Cheng KK, Zeegers MP, James ND, Devall AJ, et al: Methylation of HOXA9 and ISL1 predicts patient outcome in high-grade non-invasive bladder cancer. PLoS One. 10:e01370032015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Abe M, Watanabe N, McDonell N, Takato T, Ohira M, Nakagawara A and Ushijima T: Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis. Oncology. 74:50–60. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Van Egeren D, Escabi J, Nguyen M, Liu S, Reilly CR, Patel S, Kamaz B, Kalyva M, DeAngelo DJ, Galinsky I, et al: Reconstructing the lineage histories and differentiation trajectories of individual cancer cells in myeloproliferative neoplasms. Cell Stem Cell. 28:514–523.e9. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Psaila B, Wang G, Rodriguez-Meira A, Li R, Heuston EF, Murphy L, Yee D, Hitchcock IS, Sousos N, O'Sullivan J, et al NIH Intramural Sequencing Center, : Single-cell analyses reveal megakaryocyte-biased hematopoiesis in myelofibrosis and identify mutant clone-specific targets. Mol Cell. 78:477–492.e8. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
O'Sullivan JM and Harrison CN: Myelofibrosis: Clinicopathologic features, prognosis, and management. Clin Adv Hematol Oncol. 16:121–131. 2018.PubMed/NCBI
|
|
31
|
Cooley LF, El Shikh ME, Li W, Keim RC, Zhang Z, Strauss JF, Zhang Z and Conrad DH: Impaired immunological synapse in sperm associated antigen 6 (SPAG6) deficient mice. Sci Rep. 6:258402016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li W, Mukherjee A, Wu J, Zhang L, Teves ME, Li H, Nambiar S, Henderson SC, Horwitz AR, Strauss JF III, et al: Sperm associated antigen 6 (SPAG6) regulates fibroblast cell growth, morphology, migration and ciliogenesis. Sci Rep. 5:165062015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tewari R, Bailes E, Bunting KA and Coates JC: Armadillo-repeat protein functions: Questions for little creatures. Trends Cell Biol. 20:470–481. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tefferi A and Barbui T: Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management. Am J Hematol. 94:133–143. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Carobbio A, Guglielmelli P, Rumi E, Cavalloni C, De Stefano V, Betti S, Rambaldi A, Finazzi MC, Thiele J, Vannucchi AM, et al: A multistate model of survival prediction and event monitoring in prefibrotic myelofibrosis. Blood Cancer J. 10:1002020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tefferi A, Guglielmelli P, Larson DR, Finke C, Wassie EA, Pieri L, Gangat N, Fjerza R, Belachew AA, Lasho TL, et al: Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis. Blood. 124:2507–2513; quiz 2615. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tefferi A, Lasho TL, Finke CM, Knudson RA, Ketterling R, Hanson CH, Maffioli M, Caramazza D, Passamonti F and Pardanani A: CALR vs. JAK2 vs MPL-mutated or triple-negative myelofibrosis: Clinical, cytogenetic and molecular comparisons. Leukemia. 28:1472–1477. 2014. View Article : Google Scholar : PubMed/NCBI
|
